Follow
New Drug Application (NDA) are the documents about the product you want to manufacture and those are submitted to the government to detail the product and its usage. This document may take months to years to be approved, so it is important to submit the correct NDA for approval.
What is NDA?
If you want to market a new drug in the United States, it is required to submit a New Drug Application (NDA). NDA application is submitted to FDA and it takes several months for approval. During this time FDA reviews the application and confirms that it is complete and meets their requirements. Drug developers can start clinical trials after the NDA is accepted by the FDA. If everything remains fine then drug products will be available in the market in the near future.
How to Apply for NDA?
There are a few things to know if you are applying for a New Drug Application (NDA). The application process is complicated and lengthy but a qualified consultant can help to apply successfully. Following are some tips for applying for an NDA.
1. Start the process of finding a qualified consultant. A consultant will help you to follow the process step by step and answer the questions you may have during the whole application process.
2. Before submission, make sure that the application is complete and accurate. Incorrect and misleading information can lead to delay or rejection of application.
3. Write a letter to FDA to request an early decision on your application. This will tell FDA that your application is complete and ready for review. This early decision request will reduce your waiting period to get a response from the FDA.
4. Be prepared to pay for an expert assistance that is required in most of the cases. The application process for NDA is expensive and you can save money by hiring a consultant.
What are the requirements for a New Drug Application?
A New Drug Application is a document filed to the Food and Drug Administration (FDA) to get approval for the marketing of new drugs in the United States. The application must include information about the drug product, details about the manufacturing company and the research done to develop the drug product. All the documents must be duly signed by the representative authorized by the company.
The application should be submitted in duplicate and each copy should be marked with the date of receipt. The application must have a drug study prospectus that explains the research done to develop a new drug. The application must be written in English language and must be signed by the representative authorized by the company.
